Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $22,050 | 6 | 74.1% |
| Travel and Lodging | $3,622 | 13 | 12.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,224 | 2 | 7.5% |
| Food and Beverage | $1,091 | 19 | 3.7% |
| Unspecified | $785.42 | 1 | 2.6% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $26,540 | 34 | $0 (2021) |
| F. Hoffmann-La Roche AG | $2,224 | 2 | $0 (2018) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $785.42 | 1 | $0 (2017) |
| Genentech, Inc. | $158.54 | 3 | $0 (2018) |
| Genentech USA, Inc. | $64.17 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $1,350 | 1 | Merck Sharp & Dohme Corporation ($1,350) |
| 2019 | $6,199 | 8 | Merck Sharp & Dohme Corporation ($6,199) |
| 2018 | $8,284 | 13 | Merck Sharp & Dohme Corporation ($5,901) |
| 2017 | $13,940 | 19 | Merck Sharp & Dohme Corporation ($13,091) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/01/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,350.00 | General |
| 03/13/2019 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $4,950.00 | General |
| 03/13/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 03/01/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 03/01/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 03/01/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 03/01/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 02/28/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $573.34 | General |
| 02/28/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $265.37 | General |
| 06/03/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $118.40 | General |
| 04/30/2018 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $4,950.00 | General |
| 04/30/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 04/20/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $49.99 | General |
| 04/20/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $39.97 | General |
| 04/20/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $34.99 | General |
| 04/19/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $377.96 | General |
| 04/19/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $179.67 | General |
| 03/31/2018 | F. Hoffmann-La Roche AG | TECENTRIQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,454.07 | General |
| Category: BioOncology | ||||||
| 03/31/2018 | F. Hoffmann-La Roche AG | TECENTRIQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $769.97 | General |
| Category: BioOncology | ||||||
| 01/21/2018 | Genentech, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: BioOncology | ||||||
| 01/15/2018 | Genentech, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $81.40 | General |
| Category: BioOncology | ||||||
| 01/15/2018 | Genentech, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $68.16 | General |
| Category: BioOncology | ||||||
| 12/18/2017 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 11/01/2017 | NOVARTIS PHARMACEUTICALS CORPORATION | TAFINLAR (Drug) | — | In-kind items and services | $785.42 | Research |
| Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: ONCOLOGY | ||||||
| 08/02/2017 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $4,950.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATION SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $785.42 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 4 | 190 | 349 | $134,533 | $38,031 |
| 2020 | 9 | 236 | 347 | $111,417 | $26,276 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 93 | 241 | $89,041 | $26,999 | 30.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 41 | 41 | $24,826 | $5,983 | 24.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 45 | 56 | $15,129 | $3,866 | 25.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 11 | 11 | $5,537 | $1,183 | 21.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 73 | 142 | $36,983 | $7,992 | 21.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 39 | 61 | $21,593 | $5,388 | 25.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 30 | 30 | $17,565 | $3,766 | 21.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 17 | 34 | $10,470 | $2,816 | 26.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 21 | 21 | $10,183 | $2,143 | 21.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 12 | 12 | $7,164 | $1,923 | 26.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 14 | 14 | $4,430 | $1,187 | 26.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 18 | 20 | $2,200 | $815.40 | 37.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 12 | 13 | $829.00 | $245.87 | 29.7% |
About Dr. Autumn Mcree, MD
Dr. Autumn Mcree, MD is a Hematology & Oncology healthcare provider based in Chapel Hill, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1609923499.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Autumn Mcree, MD has received a total of $29,772 in payments from pharmaceutical and medical device companies, with $1,350 received in 2021. These payments were reported across 41 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($22,050).
As a Medicare-enrolled provider, Mcree has provided services to 426 Medicare beneficiaries, totaling 696 services with total Medicare billing of $64,307. Data is available for 2 years (2020–2021), covering 13 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Chapel Hill, NC
- Active Since 01/04/2007
- Last Updated 06/08/2012
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1609923499
Products in Payments
- TECENTRIQ (Biological) $2,383
- TAFINLAR (Drug) $785.42
- Avastin (Biological) $64.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Chapel Hill
Dr. Thomas Stinchcombe, Md, MD
Hematology & Oncology — Payments: $332,239
Jared Weiss, M.d, M.D
Hematology & Oncology — Payments: $304,374
Dr. Nigel Key, Md, MD
Hematology & Oncology — Payments: $204,110
Dr. Alice Ma, Md, MD
Hematology & Oncology — Payments: $107,585
Dr. Norman Sharpless, Md, MD
Hematology & Oncology — Payments: $72,173
Dr. Lisa Carey, Md, MD
Hematology & Oncology — Payments: $58,769